is breast parenchyma cancer

Release time ：Dec-17,2024

Breast parenchymal carcinoma is a malignant tumor that typically arises in the glandular tissue of the breast. Symptoms may include lumps, skin retraction, or nipple discharge, and a medical examination is necessary for a definitive diagnosis.

During the diagnosis of breast parenchymal carcinoma, physicians usually initiate with a clinical examination to detect any abnormal masses or structural changes in the breast. Following this, imaging studies such as breast ultrasound, mammography (commonly referred to as a mammogram), or magnetic resonance imaging (MRI) may be performed to ascertain the nature and location of the mass. If imaging suggests suspicious malignancy, a biopsy may be recommended, where a small tissue sample is taken from the area of concern for pathological analysis, which is considered the gold standard for confirming breast parenchymal carcinoma.

For patients diagnosed with breast parenchymal carcinoma, treatment plans are tailored based on the specific cancer type, stage, patient age, and overall health status. Treatment options commonly include surgical excision, radiation therapy, chemotherapy, and targeted therapies specific to certain cancer types. Throughout the treatment, patients should closely monitor their bodily responses and undergo regular follow-ups and assessments to facilitate timely adjustments to the treatment regimen.

Early detection and intervention are crucial for breast parenchymal carcinoma. Women should perform regular self-examinations and have at least one professional breast examination annually. Any detected abnormalities should prompt immediate medical consultation and professional guidance. Additionally, during treatment, patients should adhere to their physician's recommendations, actively engage in treatment, and maintain a positive attitude, which is essential for enhancing treatment outcomes and quality of life.